You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Pan-HER TKI

Showing 1 - 25 of 2,779
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy Trial (Trastuzumab Emtansine for Injection, Pyrotinib Maleate

Not yet recruiting
  • HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy
  • Trastuzumab Emtansine for Injection
  • Pyrotinib Maleate Tablets
  • (no location specified)
Sep 30, 2022

HER2 Mutation-Related Tumors, HER2 Amplified Solid Tumors Trial in Miami Beach, Kansas City (ARX788)

Withdrawn
  • HER2 Mutation-Related Tumors
  • HER2 Amplified Solid Tumors
  • Miami Beach, Florida
  • +1 more
Apr 22, 2022

Safety Trial in GuangZhou (Almonertinib combine with Pyrrolitinib)

Recruiting
  • Safety
  • Almonertinib combine with Pyrrolitinib
  • GuangZhou, Guang Dong, China
    Sun Yat-sen University Cancer Center
Mar 4, 2021

Breast Tumors, Gastric Tumor, Solid Tumors Trial in Australia, United States (ARX788)

Recruiting
  • Breast Neoplasms
  • +2 more
  • Los Angeles, California
  • +8 more
Feb 25, 2022

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

HER2-positive Breast Cancer, Brain Metastases Trial in Beijing, Guangzhou, Hangzhou (Trastuzumab, Taxanes, Pertuzumab)

Not yet recruiting
  • HER2-positive Breast Cancer
  • Brain Metastases
  • Beijing, Beijing, China
  • +2 more
May 28, 2021

Penile Tumors, Carcinoma, Squamous Cell Trial in Milan (Dacomitinib)

Completed
  • Penile Neoplasms
  • Carcinoma, Squamous Cell
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
May 12, 2021

Glioblastoma, Brain Tumor, Recurrent Trial in Spain (PF-299804 (Dacomitinib))

Completed
Has Results
  • Glioblastoma
  • Brain Tumor, Recurrent
  • PF-299804 (Dacomitinib)
  • Badalona, Barcelona, Spain
  • +11 more
Jul 2, 2021

Oncology Trial in Nashville, San Antonio (Sym013)

Terminated
Has Results
  • Oncology
  • Nashville, Tennessee
  • +2 more
Aug 27, 2020

Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial

Not yet recruiting
  • Malignant Female Reproductive System Neoplasm
  • +3 more
  • Biopsy
  • +7 more
  • (no location specified)
Nov 9, 2023

Carcinoma, Non-Small Cell Lung, EGFR Gene Mutation Trial in Changsha (Gemcitabine platinum combined with erlotinib)

Recruiting
  • Carcinoma, Non-Small Cell Lung
  • EGFR Gene Mutation
  • Gemcitabine platinum combined with erlotinib
  • Changsha, Hunan, China
    Hunan Province Tumor Hospital
Feb 28, 2022

Chemo-induced Nausea and Vomiting (CINV) Trial in Shanghai (Granisetron Transdermal Delivery System)

Recruiting
  • Chemotherapy-induced Nausea and Vomiting (CINV)
  • Granisetron Transdermal Delivery System
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Apr 19, 2022

Advanced Breast Cancer Trial in Puerto Rico, United States (ARV-471, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Coconut Creek, Florida
  • +13 more
Jan 27, 2023

Breast Cancer Stage II Trial in Xi'an (Anlotinib)

Recruiting
  • Breast Cancer Stage II
  • Xi'an, Shannxi Province, China
    Xijing Hospital Affiliated to Air Force Military Medical Univers
Sep 25, 2022

HER2-Positive Cancer Trial in Wuhan

Active, not recruiting
  • HER2-Positive Cancer
    • Wuhan, Hubei, China
      TongjiHospital
    Sep 7, 2022

    Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma, Recurrent Adenoid Cystic Carcinoma Trial in Boston (CB-103,

    Not yet recruiting
    • Adenoid Cystic Carcinoma
    • +2 more
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 14, 2023

    Breast Cancer Trial in Guangzhou (Take probiotics)

    Recruiting
    • Breast Cancer
    • Take probiotics
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Mar 6, 2023

    NSCLC Trial in Charleston (Sotorasib and Tarloxotinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Sotorasib and Tarloxotinib
    • Charleston, South Carolina
      Hollings Cancer Center at Medical University of South Carolina
    Mar 28, 2022

    Breast Cancer Trial in Guangzhou (Inetetamab, Pyrotinib, Capecitabine)

    Recruiting
    • Breast Cancer
    • Guangzhou, Guangdong, China
      Sun Yat Sen Memorial Hospital，Sun Yat sen University
    Dec 18, 2020

    Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for

    Recruiting
    • Hepatocellular Carcinoma Non-resectable
    • TACE
    • +8 more
    • Quanzhou, Fujian, China
    • +3 more
    Jan 29, 2023

    NSCLC, Epidermal Growth Factor Receptor, Leptomeningeal Metastasis Trial (Pemetrexed)

    Not yet recruiting
    • Carcinoma, Non-Small-Cell Lung
    • +2 more
    • (no location specified)
    Mar 27, 2023

    Breast Cancer, HER2-positive Breast Cancer Trial in Zhengzhou (Albumin paclitaxel+trastuzumab+pyrrolitinib,

    Active, not recruiting
    • Breast Cancer
    • HER2-positive Breast Cancer
    • Zhengzhou, Henan, China
      Henan cancer hospital
    Jun 23, 2023

    Breast Cancer, Hormone-receptor Positive Breast Cancer Trial in Guangzhou (Pyrotinib, Epirubicin, Doxorubicin Hydrochloride

    Recruiting
    • Breast Cancer
    • Hormone-receptor Positive Breast Cancer
    • Guangzhou, Guangdong, China
      Sun-Yat-Sen Memorial Hospital of Sun-Yat-Sen University
    Apr 29, 2021

    HER2-positive or Mutated Advanced Colorectal Cancer Trial (Tislelizumab)

    Not yet recruiting
    • HER2-positive or Mutated Advanced Colorectal Cancer
    • (no location specified)
    May 16, 2022

    NSCLC Trial (Furmonertinib)

    Not yet recruiting
    • Non-Small Cell Lung Cancer
    • (no location specified)
    Aug 10, 2023